W7K-21788-54735
4 vaccinations
10 coded responses
51 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 857 / AZ
- Registered
- 2020-12-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-26
Registered in v-safe
-
2020-12-26
Dose 1 — Pfizer-BioNTech
- 2020-12-26
-
2020-12-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2020-12-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2020-12-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-01-01
- 2021-01-02
-
2021-01-09
Survey response — day 14, dose 1MedDRA: Abdominal discomfort, Chills, Headache, Pyrexia — Feeling: Good · Be unable to workFree text: Fever and chills on Monday with headache and upset stomachMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-09
-
2021-01-16
Dose 2 — Pfizer-BioNTech
- 2021-01-16
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-01-23
- 2021-01-30
- 2021-02-03
- 2021-02-03
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-04-17
- 2021-07-17
-
2021-09-28
Dose 3 — Pfizer-BioNTech
- 2021-09-28
- 2021-09-29
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Throat irritation — Feeling: Fair · Headache, Fatigue or tirednessFree text: Scratchy throatMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Cough, Respiratory tract congestion, Sneezing — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Congestion, cough, sneezingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain, Respiratory tract congestion, Sneezing — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Sneezing, congestion, sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Sneezing, runny nose, congestionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — day 7, dose 3MedDRA: Oropharyngeal pain, Sneezing — Feeling: FairFree text: Sneezing, sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-10-12
Survey response — day 14, dose 3MedDRA: Discomfort, Headache, Nasal discharge discolouration, Sinusitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Symptoms of a sinus infection. Copious yellow diacharge from nose, headache, facial pressureMedDRA releases: 2024-11 · check-in free text available
- 2021-10-19
-
2021-10-26
Survey response — day 28, dose 3MedDRA: Breast feeding, Mastitis — Feeling: GoodFree text: Mastitis, I am breast feeding.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-02
- 2021-11-09
- 2021-12-30
- 2022-03-29
-
2022-09-29
Dose 4 — Pfizer-BioNTech
- 2022-09-30
-
2022-09-30
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-10-01
- 2022-10-02
-
2022-10-03
Survey response — days 1–6 daily, dose 4MedDRA: Eye discharge, Ocular hyperaemia — Feeling: GoodFree text: Red eyes with some dischargeMedDRA releases: 2024-11 · check-in free text available
- 2022-10-04
- 2022-10-05
- 2022-10-06
- 2022-10-13
- 2022-10-22
- 2022-10-27
- 2022-12-31
-
2023-03-30
Survey response — 6 months, dose 4MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-30
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-03-31
Call successfulNot applicable - Accidental Reporting
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-26 | Pfizer-BioNTech | |
| 2 | 2021-01-16 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
| 4 | 2022-09-29 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-09 | Unsuccessful | |
| 2021-01-17 | Unsuccessful | |
| 2023-03-30 | Successful 2023-03-31 |
Not applicable - Accidental Reporting |
Free text
Release 1 — day 14, dose 1
Symptoms: Fever and chills on Monday with headache and upset stomach
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Scratchy throat
Systemic reaction (other): Congestion, cough, sneezing
Systemic reaction (other): Sneezing, congestion, sore throat
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Sneezing, runny nose, congestion
Release 10 — day 7, dose 3
Systemic reaction (other): Sneezing, sore throat
Release 10 — day 14, dose 3
Symptoms: Symptoms of a sinus infection. Copious yellow diacharge from nose, headache, facial pressure
Release 10 — day 28, dose 3
Symptoms: Mastitis, I am breast feeding.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Red eyes with some discharge
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | ✓ | ✓ | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Breast feeding | · | · | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Discomfort | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Mastitis | · | · | ✓ |
| SD | Nasal discharge discolouration | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Eye discharge | · | · | ✓ |
| SRO | Ocular hyperaemia | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Sneezing | · | · | ✓ |
| SRO | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release